Source: United States Department of Justice Criminal Division
A Chinese national and a Las Vegas man have been charged by federal indictment for their roles in a scheme to import large quantities of the powerful synthetic opioid protonitazene in the U.S. and distribute it as counterfeit pills. These charges stem from an investigation by the U.S. Drug Enforcement Administration (DEA) and the U.S. Postal Inspection Service (USPIS), with assistance and collaboration with the People’s Republic of China’s Ministry of Public Security.